Qualls Stevens, DO
Neurological Surgery · Midwest City, OKNPI 1679759625
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $13,500 of the $20,946 with a category attached, or 64.5%. Collagen Matrix, Inc accounts for 64.5% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2021 at $15,669 and has fallen 99.9% since, to $17 in 2025.
Across 64 payments — averaging $327.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Collagen Matrix, Inc$14K
- AbbVie$5K
- Abbott$1K
- Nevro Corp.$462
- Alphatec Spine, Inc$353
- Medtronic$284
- plus $139 from 4 others
What the payments were for
- Consulting fees$13,50064%
- Speaking & faculty fees$5,03524%
- Food & beverage$2,41112%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Collagen Matrix, Inc | 4 | $13,500 |
| AbbVie(2 entities) | 7 | $5,092 |
| Abbott | 26 | $1,116 |
| Nevro Corp. | 5 | $462 |
| Alphatec Spine, Inc | 11 | $353 |
| Medtronic | 5 | $284 |
| Pylant Medical | 2 | $52 |
| Virtus Pharmaceuticals LLC | 2 | $35 |
| CTL Medical Corporation | 1 | $34 |
| Orthofix Medical, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$20,946 in reported general payments places this provider in the 75th percentile of 80 neurological surgery providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Naloxone Hcl | 27 | $1,654 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 106 | $907 |
| Tizanidine Hcl | 69 | $331 |
| Gabapentin | 36 | $304 |
| Cephalexin | 51 | $212 |
| Diazepam | 89 | $186 |
| Methylprednisolone | 19 | $167 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 24 | $154 |
| Cyclobenzaprine Hcl | 21 | $134 |
| Oxycodone Hcl | 29 | $132 |
| Tramadol Hcl | 25 | $96 |
| Clindamycin Hcl | 15 | $83 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Midwest City
- Brian SnellOklahoma City$3.7M
- Fadi NasrOklahoma City$1.6M
- Clinton BairdTulsa$621K
- Robert TibbsOklahoma City$537K
- Michael HahnOklahoma City$267K
- Christopher BarryEdmond$181K
- Isaac KarikariOklahoma City$137K
- Joseph CoxOklahoma City$123K
- Michael ThambuswamyTulsa$92K
- Daniel HarwellTulsa$63K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.